Dr. Melissa Kenevan, MD

Dr. Kenevan practices at Mayo Clinic Health System in Eau Claire in Eau Claire, Wisconsin, part of Mayo Clinic.

Dr. Kenevan's NPI, 1114314838, was assigned on April 21, 2015. Dr. Kenevan holds Wisconsin license 74039.

Dr. Kenevan's primary practice is Mayo Clinic Health System in Eau Claire, at 1221 Whipple St, Eau Claire, WI 54703 in Eau Claire County. The practice phone is (715) 838-3311.

Dr. Kenevan's primary practice is Mayo Clinic Health System in Eau Claire in Eau Claire, Wisconsin, part of Mayo Clinic. Dr. Kenevan is also affiliated with Mayo Clinic Health System in Menomonie. The medical group on file is Mayo Clinic Health System in Eau Claire. Dmand AI also links Dr. Kenevan to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kenevan practices, 5 sites in all. Vendor and product names are available with a free account.

Pain medicine is Dr. Kenevan's primary specialty in the NPI Registry, under taxonomy code 208VP0000X. The record also lists pain medicine. Dmand AI has Dr. Kenevan's licenses on file in 2 states: Wisconsin and Minnesota.

CMS data shows 359 Medicare services from Dr. Kenevan across 11 procedure codes in 2024, for 194 Medicare patients. Medicare paid $20,892 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 194 Medicare patients who saw Dr. Kenevan in 2024. The largest group is 65 to 74, with 80 patients. 75% of them have arthritis, and 65% have high blood pressure. 24% are also on Medicaid. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kenevan's median patient age at 74, with 60% women.

In 2024, Dr. Kenevan wrote 72 Medicare Part D claims for 36 patients. 93% of them were for generic drugs. CMS names the drug for 47 of them, across 3 drugs with 11 or more claims each, at $160 in total drug cost. In 2023, CMS named 40 claims across 2 drugs.

Dr. Kenevan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Kenevan, published from 2018 to 2019. 2019 was the busiest year, with 2. Dr. Kenevan's most frequent co-authors are Bhargavi Gali, MD, Timothy R. Long, MD and Emily Elizabeth Sharpe, MD.

CMS Open Payments shows 15 general payments to Dr. Kenevan from 6 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 79% of the total. Nevro Corp. paid the most, $471.